FARMACOVIGILÂNCIA VETERINÁRIA E A SAÚDE HUMANA: UMA REVISÃO DOS PROGRAMAS SELECIONADOS DE NOTIFICAÇÃO DE EVENTOS ADVERSOS A MEDICAMENTOS VETERINÁRIOS

Drug safety profile is an important theme throughout the world. Recently, it has gained importance in the field of veterinary medicines. In Brazil, Ministry of Agriculture Portaria SDA 152/2008 submits to the public consultation the draft of a National Program of Veterinary Pharmacovigilance. Taking into consideration the health risk to exposed human beings, the objectives of this paper are: characterization of veterinary pharmacovigilance and its usefulness for the Public Health, the description of established veterinary pharmacovigilance programs from the United States of America, the European Union and the United Kingdom, and the analysis of the Brazilian Program of veterinary pharmacovigilance draft.O perfil de segurança dos medicamentos é tema de importância mundial, e objeto que recentemente ganha relevância quanto aos medicamentos veterinários. No Brasil, a Portaria SDA nº 152/2008 do Ministério da Agricultura submeteu à consulta pública o Programa Nacional de Farmacovigilância Veterinária. Considerando o risco que a exposição aos produtos veterinários representa à saúde humana, são objetivos deste trabalho: a caracterização da Farmacovigilância Veterinária e sua utilidade para a Saúde Pública, a descrição dos Programas estabelecidos nos Estados Unidos, União Europeia e Reino Unido, e a análise da Proposta de Programa Brasileiro de Farmacovigilância Veterinária

Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology

The objective of this paper is to explore and analyze the results of the Diagnosis of the Pharmaceutical Situation in Brazil (DiagAF-Br) from a regional perspective. The study made use of an exploratory approach of multiple cases based on the DiagAF-Br data collected in five Brazilian states. A descriptive analysis of selected indicators was performed in each of the Brazilian states in three pharmaceutical dimensions: access, quality, and rational use of medicines. The mainly results concerning the “percentage of completed prescriptions” varied from 1.1% in the State of Goiás to 98.6% in Espírito Santo; the “percentage of patients who know how to take their medicines” varied from 60.4% in Sergipe to 93.3% in Rio Grande do Sul. Educational level showed to be an important predictor of knowledge on how to use medicines, especially relevant when prescription is completed. The “average number of prescribed medicines”, approximately 2.1, did not show any difference between the visited sites. Different levels of management capacity and services organization were identified, suggesting the need for more adequate strategies to improve access, quality and mainly rational use of medicines in Brazil